Gsa Capital Partners LLP Atossa Therapeutics, Inc. Call Options Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATOS
# of Institutions
83Shares Held
24.2MCall Options Held
63.6KPut Options Held
53.2K-
Black Rock Inc. New York, NY9.2MShares$7.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$4.49 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.97MShares$2.29 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.81MShares$1.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$1 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $97.5M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...